We provide timely, manageable, and actionable insights to support client decisions across the product life cycle, through a judicious mix of scientific research, primary and secondary competitive intelligence, and data analytics.
Our multiple centers of excellence (CoEs) work as extended arms of our clients.
We enable objective benchmarking of our client's research, commercialization, and marketing activities against competition.
We ensure a thorough and complete perspective of the available intelligence through our primary market research (PMR) services. We conduct multiple surveys across all physician specialties, patients, formulary decision makers, pharmacy personnel, and managed care executives to ensure delivery of a holistic solution to our clients.
Leveraging our rigorous business process designs, proprietary tools, and robust analytic methodologies, we offer dashboard development services covering multiple datasets such as sales data, promotional data, patient-level data, and prescription data.
We provide forecasts across all stages of a product's life cycle, including patient- and market-based models focused on a single product or a complete portfolio.
We excerpt and process published data in the area of life sciences, chemistry, medicine, biomedicine, and pharmacy to user-friendly databases or reports, with a focus on enabling scientists gain access to the right information easily.
We understand that health economics is an amalgamation of diverse factors and offer unique partnership solutions to help our clients develop products of clinical significance with optimum cost benefit.
Leveraging our domain expertise and employing a combination of secondary and primary research, we provide our clients with comprehensive and insightful analyses that help develop effective strategies for leadership in the vaccines area.
The key opinion leader (KOL) services of Indegene focus on enabling clients to maintain and nurture productive relationships with KOLs. We identify and maintain a large network of thought leaders across multiple regions based on proven proprietary methodology comprising both primary and secondary research.
We support key biopharmaceutical majors and biosimilar players in monitoring the emerging biologics space. We have a network of industry opinion leaders across China, India, and South Korea to effectively track development in the biosimilar space of these important regions.
We provide complete conference coverage from the selection of relevant conferences to the provision of strategic advising.
We have an wide array of networks, including key opinion leaders (KOLs), primary market agencies, and industry associations, to ensure that intelligence about some of the most important markets of the world is made available to our clients despite the lack of relevant market data in the secondary domain.
Our long history of working in these markets positions it uniquely to serve as a single-point partner to our clients and help them gain leadership in these markets.
